MORGAN STANLEY - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,304,541
-43.9%
1,900,783
-38.1%
0.00%
-33.3%
Q2 2023$32,647,126
-18.3%
3,068,339
-19.2%
0.00%
-25.0%
Q1 2023$39,965,405
+21.3%
3,798,993
+42.9%
0.00%0.0%
Q4 2022$32,938,902
+44.3%
2,658,507
+20.7%
0.00%
+33.3%
Q3 2022$22,829,000
-23.2%
2,203,402
-14.5%
0.00%
-25.0%
Q2 2022$29,721,000
+3.4%
2,577,531
+12.9%
0.00%0.0%
Q1 2022$28,731,000
+133.9%
2,283,824
+116.8%
0.00%
+100.0%
Q4 2021$12,282,000
-44.9%
1,053,422
-38.3%
0.00%
-33.3%
Q3 2021$22,304,000
+19.2%
1,707,789
+17.4%
0.00%
+50.0%
Q2 2021$18,715,000
+66.6%
1,454,153
+44.7%
0.00%0.0%
Q1 2021$11,234,000
-22.3%
1,004,793
-20.8%
0.00%0.0%
Q4 2020$14,449,000
+79.6%
1,268,521
+41.8%
0.00%0.0%
Q3 2020$8,047,000
+525.7%
894,711
+617.9%
0.00%
Q2 2020$1,286,000
+153.1%
124,633
+147.6%
0.00%
Q1 2020$508,000
-87.4%
50,339
-83.4%
0.00%
-100.0%
Q4 2019$4,034,000
+286.0%
303,060
+149.2%
0.00%
Q3 2019$1,045,000
+5.8%
121,595
+34.7%
0.00%
Q2 2019$988,000
-81.5%
90,293
-77.1%
0.00%
-100.0%
Q1 2019$5,335,000
-30.1%
394,334
-46.5%
0.00%0.0%
Q4 2018$7,637,000
+60.6%
737,128
+186.1%
0.00%
+100.0%
Q3 2018$4,755,000
-31.1%
257,608
-28.6%
0.00%
-50.0%
Q2 2018$6,903,000
+32.6%
361,036
+7.0%
0.00%
+100.0%
Q1 2018$5,205,000
+10.7%
337,345
+7.5%
0.00%0.0%
Q4 2017$4,704,000
+24.7%
313,795
+31.1%
0.00%0.0%
Q3 2017$3,773,000
+10.5%
239,306
+32.3%
0.00%0.0%
Q2 2017$3,416,000
-53.9%
180,942
-58.4%
0.00%0.0%
Q1 2017$7,412,000
-49.4%
434,456
-54.7%
0.00%
-50.0%
Q4 2016$14,658,000
+496.8%
958,760
+519.9%
0.00%
+100.0%
Q3 2016$2,456,000
+9.5%
154,653
-9.9%
0.00%0.0%
Q2 2016$2,243,000
-57.7%
171,596
-64.6%
0.00%
-50.0%
Q1 2016$5,297,000
-52.6%
484,217
-49.8%
0.00%
-50.0%
Q4 2015$11,170,000
+5.8%
963,822
-4.9%
0.00%0.0%
Q3 2015$10,560,000
-86.1%
1,013,524
-83.9%
0.00%
-84.6%
Q2 2015$76,143,000
-33.7%
6,313,653
-12.1%
0.03%
-38.1%
Q1 2015$114,871,000
-3.0%
7,179,439
-7.1%
0.04%
-2.3%
Q4 2014$118,374,000
+13.4%
7,726,761
-4.1%
0.04%
+7.5%
Q3 2014$104,343,000
-15.8%
8,054,267
-0.4%
0.04%
-18.4%
Q2 2014$123,929,000
+23.7%
8,084,120
-0.6%
0.05%
+16.7%
Q1 2014$100,150,000
+3.0%
8,129,015
-3.0%
0.04%
+2.4%
Q4 2013$97,280,000
-13.8%
8,378,965
-12.1%
0.04%
-22.6%
Q3 2013$112,865,000
+16.9%
9,532,505
-1.9%
0.05%
+8.2%
Q2 2013$96,520,0009,720,2090.05%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders